Screening

Screening has been studied in 55 papers since 2012: 2 trials and 8 observational studies in people, 38 reviews; 25 in the past year. The newest paper, Nov 18, 2026: “Effect of public health interventions on alcohol-associated cancer risk awareness and burden: A systematic scoping review”.

Intervention

55 papers study it24 findingsUpdated

Research on it is growing 32% faster than aging research as a whole: 439 papers in the latest year counted

3 new papers in 30 daysSee all 55 papers on screening

At a glance

A human study links breast cancer screening with lower mortality in women. Reviews describe mortality benefits, but a review reports no clear mortality or stroke effect in adults aged 65 or older, and another reports increased falls in frail older people. One group reports the human results; a paper declares company ties.

24 findings in 17 papers from 2016 to 2026, 5 of them since April 2026

The findings reach people, from one lab or study. 9 independent labs in 6 countries.

“After adjustment, screen detection was independently associated with 43% lower mortality (hazard ratio = 0.57, P = .003).”
Breast Cancer Method of Detection: Screening Associated With Favorable Tumor Characteristics, Treatment, and Survival Across Age GroupsJournal of the American College of Radiology : JACR2026doi:10.1016/j.jacr.2026.09.003

1 of its findings points the other way.

Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 9 independent labs in 6 countries
  • 1 finding against
  • Funders: National Institute for Health Research and others
  • 1 of 13 findings with company ties
  • Human trial2
  • Humans8
  • In silico6

What did studies of screening find?

13

Studies of screening measured 13 outcomes; the most studied are mortality (3 studies), lifespan (2) and stroke (2).

Mortality

downin humans2no changein humans1HR 0.57

3 studies
  1. Screening is linked with lower mortality in humans (breast cancer) (43% lower mortality, HR 0.57, P = .003).

    “After adjustment, screen detection was independently associated with 43% lower mortality (hazard ratio = 0.57, P = .003).”

    Humansbreast cancerfemales

    Breast Cancer Method of Detection: Screening Associated With Favorable Tumor Characteristics, Treatment, and Survival Across Age Groups

    Journal of the American College of Radiology : JACR

  2. Screening decreases mortality in humans.

    “Screening and early detection remain essential strategies to reduce the CRC incidence and mortality”

    Review

    Epidemiology of colonic adenoma and cancer

    Clinical endoscopy

  3. Screening showed no clear effect on mortality in humans (adults >=65 years) (RR 0.97, 95% CI 0.93-1.01).

    “There was no significant difference between any AF screening versus no screening in all-cause mortality (RR 0.97; 95%CI 0.93-1.01)”

    Reviewadults >=65 years12 monthsn = 85,209

    Screening for atrial fibrillation in the elderly: A network meta-analysis of randomized trials

    European journal of internal medicine

Lifespan

upin humans1upin silico1

2 studies
  1. Screening extends lifespan in diabetic individuals.

    “Early detection in diabetic individuals through targeted biomarker screening followed by timely therapeutic intervention may significantly reduce mortality, improve survival rates, and extend patient longevity.”

    Reviewin diabetic individuals

    Targeting early diagnosis and treatment of pancreatic cancer among the diabetic population: a comprehensive review of biomarker screening strategies

    Diabetology & metabolic syndrome

  2. Screening extends lifespan in silico.

    “prolonged life expectancy”

    In silico

    Cost-effectiveness of a risk-based secondary screening programme of type 2 diabetes

    Diabetes/metabolism research and reviews

Stroke

no changein humans1downin silico1RR 0.92

2 studies
  1. Screening showed no clear effect on stroke in humans (adults >=65 years) (RR 0.92, 95% CI 0.84-1.01).

    “acute cerebrovascular accident (CVA) (RR 0.92; 95%CI 0.84-1.01)”

    Reviewadults >=65 years12 monthsn = 85,209

    Screening for atrial fibrillation in the elderly: A network meta-analysis of randomized trials

    European journal of internal medicine

  2. Screening prevents stroke in silico (visiting the GPs office) (highest impact).

    “opportunistic screening of all patients ≥65 years visiting the GPs office had the highest impact on strokes prevented.”

    In silicovisiting the GPs officeopportunistic screening

    Health economic evaluation of nation-wide screening programmes for atrial fibrillation in the Netherlands

    European heart journal. Quality of care & clinical outcomes

More on Stroke

Prognosis

upin humans1

1 study
  1. Screening improves prognosis in humans (asymptomatic patients in primary care).

    “screening fully contributes to improving patient prognosis.”

    Reviewasymptomatic patients in primary care

    Screening for adults: what's new since 2017

    Revue medicale suisse

Diagnostic accuracy

upin humans1

1 study
  1. Screening improves diagnostic accuracy in humans (for chronic diseases in high-risk populations) (AUC 0.90 (95% CI: 0.87 - 0.93)).

    “AUC was 0.90 (95% CI: 0.87 - 0.93; n = 9 studies, 8,950 participants).”

    Reviewfor chronic diseases in high-risk populationsn = 8,950

    Screening and Management Strategies for Chronic Diseases in High-Risk Populations: A Systematic Review

    Jundishapur Journal of Chronic Disease Care

Cost-effectiveness

upin humans1

1 study
  1. Screening improves cost-effectiveness in humans (women smokers) ($24 000 per quality adjusted life year).

    “screening women smokers yielded the most favourable incremental cost effectiveness ratio ($24 000 per quality adjusted life year)”

    Reviewwomen smokers

    Editor's Choice - Systematic Review on the Cost Effectiveness of Abdominal Aortic Aneurysm Screening in Women

    European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery

Cervical cancer

downin humans1

1 study
  1. Screening prevents cervical cancer in humans.

    “the disease can be prevented by screening”

    Review

    Human Papillomavirus Screening: Design and Targeting of Human Papillomavirus Genotypes

    Current topics in microbiology and immunology

More on Cervical cancer

Adverse health outcomes

no changein humans1HR 0.94

1 study
  1. Screening was not clearly linked with adverse health outcomes in humans (screening-detected vs existing CKD) (HR 0.94, 95% CI = 0.67 to 1.33).

    “There was no difference in the composite outcome between those with existing CKD and those identified through screening (HR 0.94, 95% CI = 0.67 to 1.33).”

    Humansscreening-detected vs existing CKDmedian follow-up of 3-5 yearsn = 892

    Outcomes for older people with screening-detected versus existing chronic kidney disease: a cohort study with data linkage

    BJGP open

Anticoagulants

upin humans1RR 3.26

1 study
  1. Screening increases anticoagulants in humans (adults >=65 years) (RR 3.26, 95% CI 1.15-9.23).

    “initiation of oral anticoagulation (RR 3.26; 95%CI 1.15-9.23), compared with no screening”

    Reviewadults >=65 years12 monthsn = 85,209

    Screening for atrial fibrillation in the elderly: A network meta-analysis of randomized trials

    European journal of internal medicine

More on Anticoagulants

Atrial fibrillation

upin humans1RR 2.1

1 study
  1. Screening increases atrial fibrillation in humans (adults >=65 years) (1.8% vs. 1.3%, RR 2.10, 95% CI 1.20-3.65).

    “any AF screening (either systematic or opportunistic) was associated with higher AF detection (1.8% vs. 1.3%; risk ratio [RR] 2.10; 95% confidence interval [CI] 1.20-3.65)”

    Reviewadults >=65 years12 monthsn = 85,209

    Screening for atrial fibrillation in the elderly: A network meta-analysis of randomized trials

    European journal of internal medicine

More on Atrial fibrillation

All 13

What is screening linked with?

7

Studies link screening with 7 measures, among them mortality, Helicobacter pylori infection and hypertension.

Mortality

downin humans1

1 study
  1. Screening lowers the risk of mortality in humans (screening test).

    “The aim of screening is to help detect premalignant or early-stage malignant lesions to reduce mortality.”

    Reviewscreening test

    Screening for Common Gynecologic Malignancies

    Radiographics : a review publication of the Radiological Society of North America, Inc

Helicobacter pylori infection

upin humans1

1 study
  1. Screening is associated with Helicobacter pylori infection in humans (18.0% (58/323)).

    “Among 323 participants screened, 58 (18.0%) had active H. pylori infection”

    Humans6 monthsn = 323

    Implementation of Community-Based Helicobacter pylori Screening and Navigation in High-Risk Immigrant Communities

    Health promotion practice

More on Helicobacter pylori infection

Hypertension

upin humans1+21%

1 study
  1. Screening is associated with hypertension in humans (community screening in Amman, Jordan) (20.6%).

    “Our community screening revealed a high prevalence of undiagnosed hypertension (20.6%)”

    Humanscommunity screening in Amman, Jordann = 932

    Prevalence of undiagnosed hypertension and risk assessment using a validated survey in community-based screening in Amman, Jordan

    PloS one

More on Hypertension

Urine albumin-to-creatinine ratio

upin humans1+4%

1 study
  1. Screening is associated with urine albumin-to-creatinine ratio in humans (4%).

    “4% with elevated UACR”

    Humans

    Integrating Lipoprotein(a) and Albuminuria Screening into Cardiovascular Primary Prevention: Early Outcomes from the CardioPrevent Program

    AHA Scientific Sessions 2025 abstract

More on Urine albumin-to-creatinine ratio

Lipoprotein

upin humans1+19%

1 study
  1. Screening is associated with lipoprotein in humans (19%).

    “19% of patients were identified with elevated Lp(a)”

    Humans

    Integrating Lipoprotein(a) and Albuminuria Screening into Cardiovascular Primary Prevention: Early Outcomes from the CardioPrevent Program

    AHA Scientific Sessions 2025 abstract

More on Lipoprotein

Falls risk

upin humans1RR 1.31

1 study
  1. Screening raises the risk of falls risk in humans (frail elderly persons) (RR, 1.31 [95% CI, 1.13-1.50]).

    “One RCT (n = 616) found screening of frail elderly persons associated with no difference in vision outcomes vs no screening but with significantly greater falls risk (relative risk [RR], 1.31 [95% CI, 1.13-1.50]).”

    Reviewfrail elderly personsn = 616

    Screening for Glaucoma in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force

    JAMA

Glaucoma

upin humans1

1 study
  1. Screening is associated with glaucoma in humans (family members of people with existing glaucoma).

    “regularly screening family members of people with existing glaucoma is an efficient way of detecting early glaucoma”

    Reviewfamily members of people with existing glaucoma

    Glaucoma - risk factors and current challenges in the diagnosis of a leading cause of visual impairment

    Maturitas

More on Glaucoma

Funding

1 grant since 2026

National Institute on Aging$1.8M

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    A human study links screening with lower breast cancer mortality in women; another associates it with Helicobacter pylori infection. Reviews describe lower mortality and improved prognosis. Work spans 2 independent labs in 1 country; named funding includes the Korean American Community Foundation and National Institute on Aging grants.

  2. Summary written from the findings.

Latest

Dec 2025: 1Jan 2026: 3Feb 2026: 2Mar 2026: 3Apr 2026: 1May 2026: 1Jun 2026: 0Jul 2026: 1Aug 2026: 1Sep 2026: 7Oct 2026: 2Nov 2026: 325 papers in 12 months

See all 55 papers on screening